Minimal residual disease in prostate cancer patients after primary treatment: theoretical considerations, evidence and possible use in clinical management
Abstract Minimal residual disease is that not detected by conventional imaging studies and clinically the patient remains disease free. However, with time these dormant cells will awaken and disease progression occurs, resulting in clinically and radiological detectable metastatic disease. This revi...
Guardado en:
Autor principal: | Murray,Nigel P. |
---|---|
Lenguaje: | English |
Publicado: |
Sociedad de Biología de Chile
2018
|
Materias: | |
Acceso en línea: | http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0716-97602018000100503 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Circulating Tumor Cells as a Novel Prostate Cancer Diagnostic Tool
por: Fatemeh Khatami, et al.
Publicado: (2020) -
Circulating and disseminated tumor cells as a possible prognostic factor for oncological diseases
por: Andrei D. Kaprin, et al.
Publicado: (2021) -
The Role of the Innate Immune System in Cancer Dormancy and Relapse
por: Noah M. Chernosky, et al.
Publicado: (2021) -
Cytomorphology of Circulating Tumor Cells and Cell Clusters in Chilean Patients with Colo-Rectal Cancer
por: Murray,Nigel P, et al.
Publicado: (2012) -
Imaging of Neuroendocrine Prostatic Carcinoma
por: Ahmed Taher, et al.
Publicado: (2021)